163 related articles for article (PubMed ID: 3929599)
1. Effects of oral sulfonylureas on the spectrum of defects in non-insulin-dependent diabetes mellitus.
Owens DR
Am J Med; 1985 Aug; 79(2B):27-32. PubMed ID: 3929599
[TBL] [Abstract][Full Text] [Related]
2. UKPDS 26: Sulphonylurea failure in non-insulin-dependent diabetic patients over six years. UK Prospective Diabetes Study (UKPDS) Group.
Matthews DR; Cull CA; Stratton IM; Holman RR; Turner RC
Diabet Med; 1998 Apr; 15(4):297-303. PubMed ID: 9585394
[TBL] [Abstract][Full Text] [Related]
3. [25 years of diabetic treatment by oral hypoglycemic agents: successes and failures].
Tattersall RB
Journ Annu Diabetol Hotel Dieu; 1984; ():183-91. PubMed ID: 6443219
[No Abstract] [Full Text] [Related]
4. Glyburide and glipizide in treatment of diabetic patients with secondary failures to tolazamide or chlorpropamide.
Lev JD; Zeidler A; Kumar D
Diabetes Care; 1987; 10(6):679-82. PubMed ID: 3123183
[TBL] [Abstract][Full Text] [Related]
5. Oral sulfonylureas for the treatment of type II diabetes: an update.
Shank WA; Morrison AD
South Med J; 1986 Mar; 79(3):337-43. PubMed ID: 3082015
[TBL] [Abstract][Full Text] [Related]
6. Glucose regulation in non-insulin-dependent diabetes mellitus. Interaction between pancreatic islets and the liver.
Halter JB; Ward WK; Porte D; Best JD; Pfeifer MA
Am J Med; 1985 Aug; 79(2B):6-12. PubMed ID: 2863979
[TBL] [Abstract][Full Text] [Related]
7. [Effect of long-term therapy with sulfanylurea preparations on the relation of insulin secretion and the insulin-binding capacity of its receptors].
Balabolkin MI; Nedosugova LV
Ter Arkh; 1988; 60(12):91-6. PubMed ID: 3150136
[No Abstract] [Full Text] [Related]
8. The effect of glimepiride on pancreatic beta-cell function under hyperglycaemic clamp and hyperinsulinaemic, euglycaemic clamp conditions in non-insulin-dependent diabetes mellitus.
Clark HE; Matthews DR
Horm Metab Res; 1996 Sep; 28(9):445-50. PubMed ID: 8911981
[TBL] [Abstract][Full Text] [Related]
9. Non-insulin-dependent diabetes: 10-year outcome in relation to initial response to diet and subsequent sulfonylurea therapy.
Sönksen PH; Lowy C; Perkins JR; Lim HS
Diabetes Care; 1984; 7 Suppl 1():59-66. PubMed ID: 6376030
[TBL] [Abstract][Full Text] [Related]
10. [Pathophysiology of diabetes mellitus type 2 and the mechanism of action and indications for using hypoglycemic sulfonylurea derivatives].
Tatoń J; Koliński P
Pol Tyg Lek; 1985 May; 40(18):505-11. PubMed ID: 3892513
[No Abstract] [Full Text] [Related]
11. Treatment strategies for patients with non-insulin-dependent diabetes mellitus.
Boden G
Am J Med; 1985 Aug; 79(2B):23-6. PubMed ID: 2994471
[TBL] [Abstract][Full Text] [Related]
12. Effect of sulfonylurea withdrawal on proinsulin levels, B cell function, and glucose disposal in subjects with noninsulin-dependent diabetes mellitus.
Prigeon RL; Jacobson RK; Porte D; Kahn SE
J Clin Endocrinol Metab; 1996 Sep; 81(9):3295-8. PubMed ID: 8784086
[TBL] [Abstract][Full Text] [Related]
13. Long-term efficacy of sulfonylureas: a United Kingdom Prospective Diabetes Study perspective.
Holman RR
Metabolism; 2006 May; 55(5 Suppl 1):S2-5. PubMed ID: 16631806
[TBL] [Abstract][Full Text] [Related]
14. Kinetics-effect relations of insulin-releasing drugs in patients with type 2 diabetes: brief overview.
Melander A
Diabetes; 2004 Dec; 53 Suppl 3():S151-5. PubMed ID: 15561903
[TBL] [Abstract][Full Text] [Related]
15. Longitudinal evaluation of the effects of sulfonylurea therapy in subjects with type II diabetes mellitus.
Kolterman OG
Am J Med; 1985 Sep; 79(3B):23-33. PubMed ID: 3931459
[TBL] [Abstract][Full Text] [Related]
16. Role of sulfonylureas in non-insulin-dependent diabetes mellitus: Part I--"The pros".
Waldhäusl W
Horm Metab Res; 1996 Sep; 28(9):517-21. PubMed ID: 8911990
[No Abstract] [Full Text] [Related]
17. The pathogenesis of non-insulin-dependent diabetes: an update.
DeFronzo RA; Ferrannini E
Medicine (Baltimore); 1982 May; 61(3):125-40. PubMed ID: 7043155
[No Abstract] [Full Text] [Related]
18. Sulfonylureas in the treatment of diabetes mellitus--1985.
Gerich JE
Mayo Clin Proc; 1985 Jul; 60(7):439-43. PubMed ID: 3925246
[TBL] [Abstract][Full Text] [Related]
19. The place of sulfonylureas in the therapy for type 2 diabetes mellitus.
Del Prato S; Pulizzi N
Metabolism; 2006 May; 55(5 Suppl 1):S20-7. PubMed ID: 16631807
[TBL] [Abstract][Full Text] [Related]
20. Glyburide enhances the responsiveness of the beta-cell to glucose but does not correct the abnormal patterns of insulin secretion in noninsulin-dependent diabetes mellitus.
Shapiro ET; Van Cauter E; Tillil H; Given BD; Hirsch L; Beebe C; Rubenstein AH; Polonsky KS
J Clin Endocrinol Metab; 1989 Sep; 69(3):571-6. PubMed ID: 2503533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
